ICP-MS determination of Pt in biological fluids of patients treated with antitumor agents: evaluation of analytical uncertainty

Intraday and interday precisions and accuracies were in good agreement with the FDA criteria for the validation of analytical methods. The validation study was implemented by assessing the uncertainty evaluation for Pt determination in the different matrices according to EURACHEM/CITAC Guide.